Martha

Patient Info: Martha | Stage II

Martha had completed surgery, chemotherapy, and radiation and remained on hormone therapy while managing fatigue, lymphedema, and neuropathy.

Our Cancer StoriesRead more →

Stage I Breast Cancer: Anna's Survivor Story

Patient Info: Anna, Female, 50s | Stage I

As of 2022, Anna was in remission and on hormone therapy after lumpectomy, lymphadenectomy, and radiation therapy, while managing fatigue, cognitive symptoms, and lymphedema.

Our Cancer StoriesRead more →

Stage 0 Breast Cancer: Moira's Survivor Story

Patient Info: Moira | Stage 0

Moira completed surgery and said the stage 0 breast cancer was in remission.

Our Cancer StoriesRead more →

Breast Cancer: Lisa's Survivor Story

Patient Info: Lisa

Lisa described her breast cancer as being in remission and remained on hormone therapy while managing lymphedema, menopausal symptoms, and fear of dying.

Our Cancer StoriesRead more →

Phrenic nerve palsy after repeated radiation for left breast cancer

Patient Info: Anonymized, Female, 60s | Stage I

She was discharged on room air after steroid treatment improved the hypoxia associated with right diaphragmatic weakness.

PubMed CentralRead more →

Stage III Invasive Lobular Carcinoma: Martha's Survivor Story

Patient Info: Martha, Female, 40s | Stage III

Martha completed chemotherapy, bilateral mastectomies and 30 radiation treatments and remained on Tamoxifen as part of a planned 10-year course.

Lobular Breast Cancer AllianceRead more →

Breast Cancer: Kathleen's Survivor Story

Patient Info: Kathleen Shaffer, Female

As of November 2021, Kathleen was 10 months after lymph vessel transfer surgery and free of lymphedema symptoms after earlier breast cancer treatment; the story does not report formal cancer stage or recurrence status.

Cleveland ClinicRead more →

Breast Cancer: Brian's Patient Story

Patient Info: Brian Chrobak, Male, Under 40

Biomarkers: Hormone receptor-positive

Brian had completed neoadjuvant chemotherapy and surgery and was preparing to begin radiation and hormone therapy with curative intent. Tests showed no evidence of spread beyond the breast and axillary lymph nodes.

Cleveland ClinicRead more →

BRCA1 Breast Cancer: Muriel's Survivor Story

Patient Info: Muriel Verger, Female, Under 40

Biomarkers: BRCA1 mutation

As of October 2021, Muriel described having completed about 9 months of treatment for triple-negative breast cancer diagnosed in 2015 and focused her message on survivorship, body image, and early detection.

YouTube (FR search)Read more →

HER2-Positive Breast Cancer: Joy's Survivor Story

Patient Info: Joy Albi

Biomarkers: HER2-positive

Joy was in complete remission after the breast tumor was removed and she completed systemic chemotherapy.

Dana-FarberRead more →

Breast cancer recurrence in the mandibular condyle causing jaw pain

Patient Info: Anonymized, Female, 50s | Stage IV

Biomarkers: ER-positive; PR-positive; HER2-negative.

Metastatic Site: right mandibular condyle with extension into the…

After anastrozole and 60 Gy of radiation, her jaw pain, mouth opening, and function improved, although some discomfort remained and palliative systemic treatment was continuing.

PubMed CentralRead more →

A Surveillance Asymmetry Near a BioZorb Marker Was Benign Scar and Fat Necrosis

Patient Info: Anonymized, Female, 60s

Biomarkers: ER-positive; PR-positive; HER2-negative.

The new surveillance asymmetry was confirmed as benign fat necrosis, fibrosis, and scar tissue, with follow-up imaging planned.

PubMed CentralRead more →

A Mass Beside a BioZorb Implant Was Fat Necrosis, Not Recurrence

Patient Info: Anonymized, Female, 50s

Biomarkers: ER-positive; PR-positive; HER2-negative.

A 1.8 cm mass detected beside the BioZorb site was confirmed as fat necrosis, with continued imaging follow-up recommended.

PubMed CentralRead more →

Small Masses Near a BioZorb Marker After DCIS Treatment Were Fat Necrosis

Patient Info: Anonymized, Female, 50s

Biomarkers: ER-positive.

Small masses detected three years after DCIS treatment were confirmed as fat necrosis during ongoing surveillance.

PubMed CentralRead more →

A New BioZorb-Site Asymmetry After Triple-Negative Breast Cancer Was Fibrosis

Patient Info: Anonymized, Female, 50s

Biomarkers: ER-negative; PR-negative; HER2-negative., triple negative

A new focal asymmetry three years after treatment was confirmed as fibrosis and foreign-body reaction rather than recurrent cancer.

PubMed CentralRead more →

Local Breast Cancer Recurrence Was Found During BioZorb Surveillance

Patient Info: Anonymized, Female, 70+

Biomarkers: Initial right breast tumor: ER-positive, PR-positive, HER2-equivocal. Recurrent right breast tumor: ER-positive, HER2-negative.

Two sites of right-breast recurrence were confirmed three years after lumpectomy, leading to right mastectomy.

PubMed CentralRead more →

A New Mass Near a BioZorb Implant Was a Foreign-Body Reaction

Patient Info: Anonymized, Female, 40s

Biomarkers: ER-positive; PR-positive; HER2-negative.

Follow-up imaging after a benign biopsy showed no mammographic evidence of malignancy.

PubMed CentralRead more →

A BioZorb-Site Density Two Years After Lumpectomy Was Fat Necrosis

Patient Info: Anonymized, Female, 60s

Biomarkers: ER-positive; PR-positive; HER2-negative.

A new density at the lumpectomy site was confirmed as fat necrosis rather than recurrent cancer during ongoing surveillance.

PubMed CentralRead more →

A New Mass Three Years After Lumpectomy Was Fat Necrosis

Patient Info: Anonymized, Female, 50s

Biomarkers: ER-positive; PR-positive; HER2-negative.

A new mass detected three years after treatment was biopsy-proven fat necrosis rather than recurrent cancer.

PubMed CentralRead more →

Linda Stokes

Patient Info: Linda Stokes, Female

Biomarkers: germline CDH1 mutation

After breast cancer led to discovery of a CDH1 mutation, Linda Stokes chose bilateral mastectomy and later preventive stomach removal.

Ductal and lobular carcinoma in situ arising within a fibroadenoma

Patient Info: Anonymized, Female, 40s

Biomarkers: DCIS ER-positive and PR-positive; LCIS E-cadherin-negative.

Lumpectomy achieved tumor-free margins for the in situ disease, and she subsequently completed adjuvant radiation therapy.

PubMed CentralRead more →

Rare Tall Cell Breast Carcinoma Treated With Surgery Alone

Patient Info: Anonymized, female, 40s

Biomarkers: Weak ER and PR expression; HER2-negative; IDH2 mutation

No residual tumor or lymph-node involvement was found at completion surgery, PET-CT showed no metastases, and she remained disease-free 6 months after surgery.

PubMed CentralRead more →

Stage 0 Breast Cancer: Fiona's Patient Story

Patient Info: Fiona | Stage 0

Fiona described optimism and gratitude after treatment for stage 0 breast cancer, while continuing to live with concern that the cancer could worsen.

Our Cancer StoriesRead more →

Stage I Breast Cancer: Mariana's Patient Story

Patient Info: Mariana | Stage I

Mariana completed lumpectomy, chemotherapy, and radiation and continued to work through fear of lasting chemotherapy effects.

Our Cancer StoriesRead more →